Our data suggest that women
with histories of even highly recurrent
depressive illness are likely to discontinue
antidepressant use during attempts
to conceive or after conception.
However, such changes in treatment
should proceed while patients are informed
not only about the risk of prenatal
exposure to medication, but also
the risk of relapse associated with
changes in ongoing pharmacological
therapy